Sunshine Biopharma (SBFMW)

Profile

Full Name

Sunshine Biopharma, Inc.

Ticker Symbol

SBFMW

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

February 15, 2022

Indexes

Not included

Website

http://sunshinebiopharma.com

Employees

52

Key Details

Price

$0.58(+187.95%)

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$34.87M(+44.75% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.58
SBFMW price is $0.58

30-Day Relative Volume

0.05
SBFMW 30-day relative volume is 0.05

Price Performance

Price Most recent change

+187.95%
SBFMW price was up +187.95% on Apr 11, 2025

Price YTD change

+257.92%
SBFMW price is up +257.92% since January 1st

Price 1-year change

-
SBFMW price 1-year change is unknown

Price 3-year change

-
SBFMW price 3-year change is unknown

Price Range

Price All-time high

$0.98
SBFMW price is currently -41.25% below its historical high of $0.98

Price 3-year low

$0.12
SBFMW price is currently +379.92% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
SBFMW market capitalization value is unknown

Market cap 3-year change

-
SBFMW market capitalization 3-year change is unknown

Market cap All-time high

-
SBFMW market capitalization all-time high is unknown

Market cap sector rank

-
SBFMW market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

-
SBFMW shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
SBFMW shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

3.61
SBFMW beta is 3.61

200-day SMA

$0.23
SBFMW price is currently +155.50% above its 200-day simple moving average

50-day SMA

$0.24
SBFMW price is currently +144.44% above its 50-day simple moving average

RSI

68.93
SBFMW 14-day relative strength index is 68.93

Volume

0.05
SBFMW 30-day relative volume is 0.05

ATR

$0.10
SBFMW average true range is $0.10

10-day Historical Volatility

1001.37%
SBFMW 10-day historical volatility is 1001.37%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$34.87M
SBFMW annual revenue is $34.87 million

Revenue Analysts estimate

$100.00M
SBFMW annual revenue is currently -65.13% lower than the consensus analysts' forecast

Revenue 1-year change

+44.75%
SBFMW annual revenue is up +44.75% year-on-year

Revenue Sector rank

41.77%
SBFMW annual revenue is higher than 41.77% of companies in Healthcare sector

EPS

EPS

-
SBFMW annual earnings per share value is unknown

EPS Analysts estimate

-
SBFMW annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-
SBFMW annual earnings per share 1-year change is unknown

EPS Sector rank

-
SBFMW annual earnings per share is unknown

Profit

Gross profit

$10.67M
SBFMW annual gross profit is $10.67 million

Gross margin

30.60%
SBFMW annual gross profit margin is 30.60%

Operating profit

-$5.81M
SBFMW annual operating income is -$5.81 million

Operating margin

-16.67%
SBFMW annual operating profit margin is -16.67%

Net income

-$5.13M
SBFMW annual net profit is -$5.13 million

Net margin

-
SBFMW annual net profit margin value is unknown

Expenses

Total expenses

$40.69M
SBFMW annual total expenses is $40.69 million

Operating expenses

$16.48M
SBFMW annual total operating expenses is $16.48 million

Cost of goods sold

$24.20M
SBFMW annual cost of goods sold is $24.20 million

Selling, general & administrative expenses

$14.94M
SBFMW annual SGA is $14.94 million

Depreciation and amortization

$223.53K
SBFMW annual depreciation & amortization is $223.53 thousand

Interest expense

$8774.00
SBFMW annual interest expense is $8774.00

Income tax

-$234.86K
SBFMW annual income tax is -$234.86 thousand

EBIT & EBITDA

EBIT

-$5.36M
SBFMW annual earnings before interest & taxes is -$5.36 million

EBITDA

-$5.09M
SBFMW annual EBITDA is -$5.09 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$30.56M
SBFMW annual total assets is $30.56 million

Non current assets

$4.59M
SBFMW annual long term assets is $4.59 million

Current assets

$25.97M
SBFMW annual total current assets is $25.97 million

Cash and cash equivalents

$9.69M
SBFMW annual cash & cash equivalents is $9.69 million

Accounts receivable

$3.87M
SBFMW annual accounts receivable is $3.87 million

Inventory

$11.28M
SBFMW annual inventory is $11.28 million

Liabilities

Total liabilities

$7.06M
SBFMW annual total liabilities is $7.06 million

Long term liabilities

$744.72K
SBFMW annual total long term liabilities is $744.72 thousand

Current liabilities

$6.31M
SBFMW annual total current liabilities is $6.31 million

Accounts payable

$5.54M
SBFMW annual accounts payable is $5.54 million

Debt

Total debt

$952.48K
SBFMW annual total debt is $952.48 thousand

Total debt 1-year change

+44.82%
SBFMW annual total debt is up +44.82% year-on-year

Long term debt

$744.72K
SBFMW annual long term debt is $744.72 thousand

Short term debt

-
SBFMW annual short term debt value is unknown

Equity & Capital

Shareholders equity

$23.50M
SBFMW annual stockholders equity is $23.50 million

Book value

$20.47M
SBFMW annual book value is $20.47 million

Retained earnings

-$69.04M
SBFMW annual retained earnings is -$69.04 million

Working capital

$19.65M
SBFMW annual working capital is $19.65 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.53M
SBFMW annual cash flow from operations is -$12.53 million

Cash from operations 1-year change

-42.8%
SBFMW annual cash flow from operations is down -42.8% year-on-year

Cash from investing

-$2.32M
SBFMW annual cash flow from investing activities is -$2.32 million

Cash from investing 1-year change

-253.71%
SBFMW annual cash flow from investing activities is down -253.71% year-on-year

Cash from financing

$9.29M
SBFMW annual cash flow from financing activities is $9.29 million

Cash from financing 1-year change

+171.18%
SBFMW annual cash flow from financing activities is up +171.18% year-on-year

CAPEX

CAPEX

$2.32M
SBFMW annual capital expenditures is $2.32 million

CAPEX 1-year change

+194.49%
SBFMW annual capital expenditures is up +194.49% year-on-year

Free Cash Flow

Free cash flow

-$14.85M
SBFMW annual free cash flow is -$14.85 million

Free cash flow 1-year change

-55.3%
SBFMW annual free cash flow is down -55.3% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

30.60%
SBFMW annual gross profit margin is 30.60%

Operating margin

-16.67%
SBFMW annual operating profit margin is -16.67%

Net margin

-
SBFMW annual net profit margin value is unknown

ROA & ROE

ROA

-16.80%
SBFMW annual return on assets is -16.80%

ROE

-21.85%
SBFMW annual return on equity is -21.85%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SBFMW price to earnings ratio value is unknown

PE ratio Sector rank

-
SBFMW price to earnings ratio is unknown

PB Ratio

PB ratio

-
SBFMW price to book ratio value is unknown

PB ratio Sector rank

-
SBFMW price to book ratio is unknown

PS Ratio

PS ratio

-
SBFMW price to sales ratio value is unknown

PS ratio Sector rank

-
SBFMW price to sales ratio is unknown

Enterprise value

Enterprise value

-
SBFMW enterprise value value is unknown

Enterprise value Sector rank

-
SBFMW enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
SBFMW EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
SBFMW EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.11
SBFMW annual current ratio is 4.11

Quick ratio

2.33
SBFMW annual quick ratio is 2.33

Leverage

Debt to equity

0.04
SBFMW annual debt to equity ratio is 0.04

Interest coverage ratio

-610.92
SBFMW annual interest coverage ratio is -610.92

Risk & Stability

Piotroski F-Score

-
SBFMW piotroski f-score value is unknown

Altman Z-Score

-
SBFMW altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Aug 7, 23 Aegis Capital
Buy

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Sunshine Biopharma?
  • Does Sunshine Biopharma pay dividends?
  • What sector is Sunshine Biopharma in?
  • What industry is Sunshine Biopharma in?
  • What country is Sunshine Biopharma based in?
  • When did Sunshine Biopharma go public?
  • Is Sunshine Biopharma in the S&P 500?
  • Is Sunshine Biopharma in the NASDAQ 100?
  • Is Sunshine Biopharma in the Dow Jones?
  • When does Sunshine Biopharma report earnings?

What is the ticker symbol for Sunshine Biopharma?

The ticker symbol for Sunshine Biopharma is NASDAQ:SBFMW

Does Sunshine Biopharma pay dividends?

No, Sunshine Biopharma does not pay dividends

What sector is Sunshine Biopharma in?

Sunshine Biopharma is in the Healthcare sector

What industry is Sunshine Biopharma in?

Sunshine Biopharma is in the Drug Manufacturers - Specialty & Generic industry

What country is Sunshine Biopharma based in?

Sunshine Biopharma is headquartered in United States

When did Sunshine Biopharma go public?

Sunshine Biopharma's initial public offering (IPO) was on February 15, 2022

Is Sunshine Biopharma in the S&P 500?

No, Sunshine Biopharma is not included in the S&P 500 index

Is Sunshine Biopharma in the NASDAQ 100?

No, Sunshine Biopharma is not included in the NASDAQ 100 index

Is Sunshine Biopharma in the Dow Jones?

No, Sunshine Biopharma is not included in the Dow Jones index

When does Sunshine Biopharma report earnings?

The date for Sunshine Biopharma's next earnings report has not been announced yet
On this page